Effect of Roflumilast in airways disorders via dual inhibition of phosphodiesterase and Ca2+-channel
The bronchodilator effects of Roflumilast "a selective phosphodiesterase type-4 (PDE4)" inhibitor studied in this experimental protocol. The spiral strips of isolated guinea-pig tracheal chains mounted in organ bath and maintained in Krebs solution ventilated with carbogen at 32 °C and in...
Saved in:
Main Authors: | Faisal Imam (Author), Najeeb Ur Rehman (Author), Mohd Nazam Ansari (Author), Wajhul Qamar (Author), Muhammad Afzal (Author), Khalid Saad Alharbi (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2020-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Roflumilast: Review of Phosphodiesterase-4 Inhibitor as Asthma Therapy
by: Rafina Syfridiana, et al.
Published: (2021) -
Roflumilast: first phosphodiesterase 4 inhibitor approved for treatment of COPD
by: Mark A Giembycz, et al.
Published: (2010) -
Protective role of Roflumilast against cadmium-induced cardiotoxicity through inhibition of oxidative stress and NF-κB signaling in rats
by: Mohd Nazam Ansari, et al.
Published: (2019) -
Characterization of Resveratrol, Oxyresveratrol, Piceatannol and Roflumilast as Modulators of Phosphodiesterase Activity. Study of Yeast Lifespan
by: Adrián Matencio, et al.
Published: (2020) -
Validated stability-indicating HPLC-DAD method for determination of the phosphodiesterase (PDE-4) inhibitor roflumilast
by: Tarek S. Belal, et al.
Published: (2014)